Professor David Taylor
Professor David Taylor
Maudsley Hospital
Verified email at
TitleCited byYear
South London and Maudsley and Oxleas NHS Trusts Prescribing Guidelines
D Taylor, R Kerwin, C Paton
Taylor and Francis, London, 2005
2003 prescribing guidelines
D Taylor, C Paton, R Kerwin
Informa HealthCare, 2003
The Maudsley prescribing guidelines Informa Healthcare
D Taylor, C Paton, S Kapur
London, 2009
Atypical antipsychotics and weightgain—a systematic review
DM Taylor, R McAskill
Acta Psychiatrica Scandinavica 101 (6), 416-432, 2000
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
RL Carhart-Harris, M Bolstridge, J Rucker, CMJ Day, D Erritzoe, M Kaelen, ...
The Lancet Psychiatry 3 (7), 619-627, 2016
Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology
GM Goodwin, PM Haddad, IN Ferrier, JK Aronson, TRH Barnes, ...
Journal of Psychopharmacology 30 (6), 495-553, 2016
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines
A Cleare, CM Pariante, AH Young, IM Anderson, D Christmas, PJ Cowen, ...
Journal of Psychopharmacology 29 (5), 459-525, 2015
Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis
D Baldwin, R Woods, R Lawson, D Taylor
Bmj 342, d1199, 2011
Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology
OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ...
American Journal of Psychiatry 174 (3), 216-229, 2017
Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation
OD Howes, F Vergunst, S Gee, P McGuire, S Kapur, D Taylor
The British Journal of Psychiatry 201 (6), 481-485, 2012
Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia
AH Barnett, P Mackin, I Chaudhry, A Farooqi, R Gadsby, A Heald, J Hill, ...
Journal of Psychopharmacology 21 (4), 357-373, 2007
Atypical antipsychotics and hyperglycaemia
S Mir, D Taylor
International clinical psychopharmacology 16 (2), 63-74, 2001
Antipsychotics and QT prolongation
DM Taylor
Acta Psychiatrica Scandinavica 107 (2), 85-95, 2003
A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review
E Whiskey, U Werneke, D Taylor
International clinical psychopharmacology 16 (5), 239-252, 2001
Psychiatrists’ attitude towards and knowledge of clozapine treatment
J Nielsen, M Dahm, H Lublin, D Taylor
Journal of Psychopharmacology, 2010
Tolerability of atypical antipsychotics
C Stanniland, D Taylor
Drug safety 22 (3), 195-214, 2000
Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies
D Taylor, A Sparshatt, S Varma, O Olofinjana
Bmj 348, g1888, 2014
A UK audit of screening for the metabolic side effects of antipsychotics in community patients
TRE Barnes, C Paton, MR Cavanagh, E Hancock, DM Taylor, ...
Schizophrenia bulletin 33 (6), 1397-1403, 2007
The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal
S Brissos, MR Veguilla, D Taylor, V Balanzá-Martinez
Therapeutic advances in psychopharmacology 4 (5), 198-219, 2014
Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review.
DM Taylor, C Young, C Paton
The Journal of clinical psychiatry 64 (1), 30-34, 2003
The system can't perform the operation now. Try again later.
Articles 1–20